These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9345068)

  • 41. Incidence and influence of GB virus C and hepatitis C virus infection in patients undergoing bone marrow transplantation.
    Akiyama H; Nakamura N; Tanikawa S; Sakamaki H; Onozawa Y; Shibayama T; Tanaka S; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
    Bone Marrow Transplant; 1998 Jun; 21(11):1131-5. PubMed ID: 9645576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.
    Strasser SI; Myerson D; Spurgeon CL; Sullivan KM; Storer B; Schoch HG; Kim S; Flowers ME; McDonald GB
    Hepatology; 1999 Jun; 29(6):1893-9. PubMed ID: 10347135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
    Peters C; Balthazor M; Shapiro EG; King RJ; Kollman C; Hegland JD; Henslee-Downey J; Trigg ME; Cowan MJ; Sanders J; Bunin N; Weinstein H; Lenarsky C; Falk P; Harris R; Bowen T; Williams TE; Grayson GH; Warkentin P; Sender L; Cool VA; Crittenden M; Packman S; Kaplan P; Lockman LA; Anderson J; Krivit W; Dusenbery K; Wagner J
    Blood; 1996 Jun; 87(11):4894-902. PubMed ID: 8639864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
    Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
    Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].
    Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077
    [No Abstract]   [Full Text] [Related]  

  • 46. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
    Kempinska A; Kwak EJ; Angel JB
    Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
    Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
    Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine.
    Hashino S; Takahata M; Nozawa A; Izumiyama K; Chiba K; Suzuki S; Hige S; Asaka M
    Bone Marrow Transplant; 2002 Feb; 29(3):269-71. PubMed ID: 11859401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation.
    Ljungman P; Andersson J; Aschan J; Björkstrand B; Hägglund H; Lönnqvist B; Ringdén O; Winiarski J
    Clin Infect Dis; 1996 Jul; 23(1):167-9. PubMed ID: 8816147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation.
    Locasciulli A; Testa M; Pontisso P; Bacigalupo A; Ljungman P; Frickhofen N; Alberti A
    Bone Marrow Transplant; 1997 Feb; 19(3):237-40. PubMed ID: 9028552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment.
    Utili R; Zampino R; Bellopede P; Marracino M; Ragone E; Adinolfi LE; Ruggiero G; Capasso M; Indolfi P; Casale F; Martini A; Di Tullio MT
    Blood; 1999 Dec; 94(12):4046-52. PubMed ID: 10590048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
    Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
    Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term liver function of recipients with hepatitis G virus infection after bone marrow transplantation.
    Maruta A; Tanabe J; Hashimoto C; Kato K; Kanamori H; Fukawa H; Miyashita H; Fujisawa S; Fujita H; Matsuzaki M; Motomura S; Kodama F; Ookawa S; Mohri H; Ishigatsubo Y
    Bone Marrow Transplant; 1999 Aug; 24(4):359-63. PubMed ID: 10467323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of chronic viral hepatitis before and after renal transplantation.
    Gane E; Pilmore H
    Transplantation; 2002 Aug; 74(4):427-37. PubMed ID: 12352899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.
    Gayowski T; Marino IR; Singh N; Doyle H; Wagener M; Fung JJ; Starzl TE
    Transplantation; 1998 Feb; 65(4):499-504. PubMed ID: 9500623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcome of chronic hepatitis B in heart transplant recipients.
    Wedemeyer H; Pethig K; Wagner D; Flemming P; Oppelt P; Petzold DR; Haverich A; Manns MP; Boeker KH
    Transplantation; 1998 Nov; 66(10):1347-53. PubMed ID: 9846521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.